TherapeuticsMD (TXMD) Inventory (2010 - 2022)

TherapeuticsMD (TXMD) has reported Inventory for 13 consecutive years, with $6.7 million the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Inventory fell 8.98% year-over-year to $6.7 million; the trailing twelve-month figure through Sep 2022 stood at $6.7 million (down 8.98% YoY), and the FY2021 full-year result was $7.6 million, down 4.64% from the prior year.
• Inventory rose to $6.7 million in Q3 2022 per TXMD's latest filing, from $6.1 million in the prior quarter.
• Across five years, Inventory topped out at $14.6 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
• Historically, Inventory has averaged $7.3 million across 5 years, with a median of $7.5 million in 2019.
• The sharpest annual moves came in 2019 and 2021: Inventory soared 342.89% in 2019, then plunged 49.71% in 2021.
• Over 5 years, Inventory stood at $3.3 million in 2018, then jumped by 262.97% to $11.9 million in 2019, then plunged by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
• According to Business Quant data, Inventory over the past three periods registered $6.7 million, $6.1 million, and $9.0 million for Q3 2022, Q2 2022, and Q1 2022 respectively.